Complement C5a induces the generation of neutrophil extracellular traps by inhibiting mitochondrial STAT3 to promote the development of arterial thrombosis. [PDF]
Chen Y +10 more
europepmc +1 more source
Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population. [PDF]
Cyprian FS +17 more
europepmc +1 more source
Background ANCA‐associated vasculitides (AAV) are autoimmune small‐vessel vasculitides characterized by necrotizing inflammation with few immune deposits (“pauci‐immune” lesions).
Kehinde Sunmboye, Pauline Millan
doaj +1 more source
A Greater Increase in Complement C5a Receptor 1 Level at Onset and a Smaller Decrease in Immunoglobulin G Level after Recovery in Severer Coronavirus Disease 2019 Patients: A New Analysis of Existing Data with a New Two-Tailed t-Test. [PDF]
Ishida T +7 more
europepmc +1 more source
Targeting Complement C5a Receptor 1 for the Treatment of Immunosuppression in Sepsis. [PDF]
Sommerfeld O +11 more
europepmc +1 more source
Blood Transcriptome Analysis of Septic Patients Reveals a Long Non-Coding Alu-RNA in the Complement C5a Receptor 1 Gene. [PDF]
Emblem Å +7 more
europepmc +1 more source
Author Correction: Submolecular probing of the complement C5a receptor-ligand binding reveals a cooperative two-site binding mechanism. [PDF]
Dumitru AC +6 more
europepmc +1 more source
Complement C5a-triggered differentiated HL-60 stimulates migration of THP-1 monocytic leukocytes via secretion of CCL2. [PDF]
Dewan SMR, Osaka M, Deushi M, Yoshida M.
europepmc +1 more source

